Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
BICD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SNED1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COPG2IT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CEP41 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERGIC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LNPK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FLRT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GMPS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
INTS8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PNPLA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPIEL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL35A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FZD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP2B4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UST - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RSRC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
B4GALT6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on